2006AE-PCOS+将PCOS定义为高雄激素血症的标准.pdfVIP

0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology Metabolism 91(11):4237–4245 Printed in U.S.A. Copyright © 2006 by The Endocrine Society doi: 10.1210/jc.2006-0178 POSITION STATEMENT: Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline Ricardo Azziz, Enrico Carmina, Didier Dewailly, Evanthia Diamanti-Kandarakis, Hector F. Escobar-Morreale, Walter Futterweit, Onno E. Janssen, Richard S. Legro, Robert J. Norman, Ann E. Taylor, and Selma F. Witchel Cedars-Sinai Medical Center and The David Geffen School of Medicine at University of California, Los Angeles (R.A.), Los Angeles, California 90048; University of Palermo (E.C.), 90128 Palermo, Italy; Lille University Hospital (D.D.), 59037 Lille, France; University of Athens Medical School (E.D.-K.), GR-157 84 Athens, Greece; Hospital Ramon y Cajal and University of Alcala´ (H.F.E.-M.), 28801 Madrid, Spain; Mount Sinai School of Medicine (W.F.), New York, New York 10029; University of Essen (O.E.J.), 45131 Essen, Germany; Pennsylvania State University School of Medicine (R.S.L.), Hershey, Pennsylvania 17033; University of Adelaide (R.J.N.), Woodville, South Australia 5005, Australia; Pfizer Global Research and Development (A.E.T.), Groton, Connecticut 06340; and Children’s Hospital of Pittsburgh (S.F.W.), Pittsburgh, Pennsylvania 15213 Objective: The Androgen Excess Society (AES) charged a task force minority opinions noted. Statements that were not supported by peer- to review all available data and recommend an evidence-based def- reviewed evidence were not included.